Professor of Pediatrics
Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre and Nova Scotia Health Authority, Halifax, NS, Canada
Disclosure: GSK group of companies (Research Grant or Support)Immunivaccines Inc (Scientific Research Study Investigator, Research Grant or Support)Janssen (Research Grant or Support)Pfizer (Research Grant or Support)Symvivo (Scientific Research Study Investigator, Research Grant or Support)VBI Vaccines (Research Grant or Support)
Joanne M. Langley MD. MSc, FRCPC. FSHEA, FIDSA, FPIDS
Professor of Pediatrics and Community Health and Epidemiology, Dalhousie University Faculty of Medicine; Division Head, Pediatric Infectious Diseases, IWK Health Care Centre
Dr. Langley is a pediatric infectious disease physician and vaccine researcher at the Canadian Center for Vaccinology (CCfV) at Dalhousie University. She is the Associate Director for Vaccine Evaluation Group at CCfV, and works with collaborators in academia, public health, industry, and non-governmental organizations to conduct phase 1 through 4 trials. She holds the CIHR-GSK Chair in Pediatric Vaccinology at Dalhousie University. She is an active investigator in the Canadian Immunization Research Network (CIRN) and is the lead investigator for its Clinical Trials Network (CTN). Dr. Langley’s work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is the co-chair of Canada’s COVID-19 Vaccine Task Force, a member of the COVID-19 Science Expert Panel for the Chief Science Advisor of Canada, and a former member of the Canadian Task Force on Preventive Health Care and Canada’s National Advisory Committee on Immunization (Chair, 2007-2011).
https://medicine.dal.ca/departments/department-sites/pediatrics/our-people/our-faculty/joanne-langley.html
Twitter: @jmllhfx
